«

»

AstraZeneca resumes Phase 3 COVID-19 vaccine trial in the U.K.

Following an independent investigation in a trial participant's 'unexplained illness,' the company got the go-ahead to resume testing.

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive